Physician

Michael Kevin Lloyd, M.D.

According to 2025 Medicare claims, Michael Lloyd, M.D. (NPI: 1659530095) practices family practice in the Hanford-Corcoran, CA market, with the plurality of this provider's patient population coming from Kings, CA. This provider's primary affiliated billing organization is MICHAEL K LLOYD MD INC (NPI: 1740537851; TIN: 46-0734206) and primary practice location at 93230-3500. Lloyd is affiliated with the Akira Health of Fresno Inc. (ACO ID: A2366), participating under the MSSP model.

Lloyd's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 90 traditional Medicare patients, billed 559 HCPCS/CPT codes, and received $30,261 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 912 prescription claims across 117 beneficiaries totaling $78,284 in drug costs, led by Eliquis (Apixaban). DME data shows 181 claims. Open Payments data shows 1 records totaling $10. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $126,749 to $30,261. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $234,214 to $78,284. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $25,314 and ending at $11,974.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$79K$157K2015 Medicare payment: $126,749 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $119,499 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $156,686 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $157,290 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $75,161 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $85,654 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $44,992 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $45,548 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $32,353 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $30,261 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153272,044$126,749
20163072,091$119,499
20173223,036$156,686
20183333,216$157,290
20192951,482$75,161
20202941,639$85,654
2021202732$44,992
2022178674$45,548
2023112480$32,353
202490559$30,261

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$117K$234K2015 Drug cost: $234,214 (USD; Tot_Drug_Cst)2016 Drug cost: $134,808 (USD; Tot_Drug_Cst)2017 Drug cost: $84,730 (USD; Tot_Drug_Cst)2018 Drug cost: $121,126 (USD; Tot_Drug_Cst)2019 Drug cost: $69,303 (USD; Tot_Drug_Cst)2020 Drug cost: $67,291 (USD; Tot_Drug_Cst)2021 Drug cost: $75,587 (USD; Tot_Drug_Cst)2022 Drug cost: $71,497 (USD; Tot_Drug_Cst)2023 Drug cost: $88,965 (USD; Tot_Drug_Cst)2024 Drug cost: $78,284 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152814,070$234,214
20162562,419$134,808
20172291,540$84,730
20182521,631$121,126
2019228878$69,303
2020174804$67,291
2021172864$75,587
2022150861$71,497
2023113954$88,965
2024117912$78,284

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$15K$29K2015 Medicare payment: $20,848 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $13,294 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $10,756 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $12,141 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $13,729 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $18,807 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $29,021 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $22,041 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $16,725 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $6,332 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201553367$20,848
201665418$13,294
2017105456$10,756
2018128488$12,141
2019146563$13,729
202081443$18,807
202128409$29,021
202237404$22,041
202330275$16,725
202438181$6,332

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more47161$98
90662Influenza vaccine split virus, preservative free2424$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4574$67
G0008Administration of influenza virus vaccine2424$33
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's61203$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban15630$12,286
JardianceEmpagliflozin12480$9,566
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12665$1,032
Levothyroxine SodiumLevothyroxine Sodium403,240$551
Nifedipine ErNifedipine15544$512

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A7030Full face mask used with positive airway pressure device, eachNN/R17$1,203
A7032Cushion for use on nasal mask interface, replacement only, eachNN/R11$1,163
A7031Face mask interface, replacement for full face mask, eachNN/R16$1,091
A7034Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strapNN/R14$711
A4604Tubing with integrated heating element for use with positive airway pressure deviceNN/R17$639

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$10Organon Llc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Kevin Lloyd, M.D.?

Tedicare shows public-source Medicare data for Michael Kevin Lloyd, M.D. (NPI 1659530095), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Kevin Lloyd, M.D. have ACO affiliation data?

Michael Kevin Lloyd, M.D. is shown with ACO affiliation data for Akira Health of Fresno Inc. (MSSP, ACO ID A2366).

What billing organization is linked to Michael Kevin Lloyd, M.D.?

Michael Kevin Lloyd, M.D. is linked to MICHAEL K LLOYD MD INC (billing NPI 1740537851) in the available physician profile data.

Does Michael Kevin Lloyd, M.D. have Open Payments data?

Michael Kevin Lloyd, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.